1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. BOLT BIOTHERAPEUTICS INC
Bolt Biotherapeutics Inc XNAS: BOLT
6.71 -0.38 (-5.36%)
46,950

XNAS 28 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert

Bolt Biotherapeutics Inc - BOLT - stock price prediction, stock price target, analyst ratings from 5 analysts

Bolt Biotherapeutics Inc has a share price target of US$ 22, revenue growth forecast of -21.3%, and profit growth estimate of 38.9% for FY25, based on top 5 analyst calls.